Lectures

Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management

by Pravin Shukle, MD
(1)

Questions about the lecture
My Notes
  • Required.
Save Cancel
    Learning Material 2
    • PDF
      Slides HeartFailureAndAngina CardiovascularPharma.pdf
    • PDF
      Download Lecture Overview
    Report mistake
    Transcript

    00:01 The renin-angiotensin agents are very important in both chronic heart failure and in acute management of high blood pressure.

    00:09 We know that these agents reduce morbidity and mortality in heart failure.

    00:14 They reduce aldosterone secretion and water retention, and they also reduce total peripheral resistance or vascular resistance through its antihypertensive effects.

    00:24 I've listed here all of the ACE inhibitors. And here are all of the ARBs.

    00:30 Now, the angiotensin receptor blockers have been in studies shown to be "non-inferior" to ACE inhibitors.

    00:37 You'll generally find on the wards that cardiologists favor ACE inhibitors, and the ARBs are favored by everyone else.

    00:45 I don't think there is really a right answer in ACEi versus ARB.

    00:49 The direct renin inhibitors are a relatively new class that I discussed in my hypertension lecture, we don't have a lot of great information on heart failure at this time.

    00:58 Now, it's still maybe useful and beneficial in heart failure. But at this point in time, in 2016, it's not routinely used.

    01:08 Let's move on to the beta blockers. Remember that in heart failure, we only use beta blockers once the patient has been stabilized.

    01:16 Beta blockers may actually be harmful in acute heart failure because it may suppress cardiac function.

    01:23 Beta blockers work by two major ways. First of all, they reduce heart rate and increases stroke volume.

    01:31 That's because when you reduce heart rate, the heart has more time to fill, and as it has more time to fill, each stroke will become more efficient and powerful.

    01:41 It also reduces overall mortality and progression of chronic heart failure.

    01:46 Carvedilol is the favourite beta blocker in heart failure. Major studies have shown reduction of morbidity and mortality.

    01:54 Carvedilol has all alpha, beta, and beta 2 effects, so it's a very effective agent, and it's very well tolerated in heart failure.

    02:05 Nebivolol is a newer beta blocker that is just come recently to the United States and Canada and has been in Europe for several years.

    02:12 It has actions on nitric oxide. At this point in time, it's relatively investigational in the US and Canada, but there is a lot of experience in Europe which shows that it does quite well.


    About the Lecture

    The lecture Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management by Pravin Shukle, MD is from the course Cardiovascular Pharmacology. It contains the following chapters:

    • Renin-angiotensin Agents
    • β1-Blockers

    Included Quiz Questions

    1. ...has alpha-1, beta-1, and beta-2 effects.
    2. ...should not be used in chronic heart failure.
    3. ...can be used in acute decompensated heart failure.
    4. ...decreases stroke volume.

    Author of lecture Renin-Angiotensin Agents and Beta Blockers – Angina and Heart Failure Management

     Pravin Shukle, MD

    Pravin Shukle, MD


    Customer reviews

    (1)
    5,0 of 5 stars
    5 Stars
    5
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1  Star
    0